| __timestamp | PTC Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 22963000 | 20272000000 |
| Thursday, January 1, 2015 | 36766000 | 19652000000 |
| Friday, January 1, 2016 | 82705000 | 21903000000 |
| Sunday, January 1, 2017 | 194392000 | 22385000000 |
| Monday, January 1, 2018 | 264734000 | 18854000000 |
| Tuesday, January 1, 2019 | 306980000 | 16887000000 |
| Wednesday, January 1, 2020 | 380766000 | 16658000000 |
| Friday, January 1, 2021 | 538593000 | 15878000000 |
| Saturday, January 1, 2022 | 698801000 | 14925000000 |
| Sunday, January 1, 2023 | 937822000 | 15846000000 |
| Monday, January 1, 2024 | 16544000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, understanding revenue trends is crucial for investors and stakeholders. This analysis focuses on the performance of Teva Pharmaceutical Industries Limited and PTC Therapeutics, Inc. over the past decade.
From 2014 to 2023, Teva's revenue experienced a decline of approximately 22%, dropping from $20.3 billion to $15.8 billion. This trend reflects the challenges faced by the company in a competitive market. In contrast, PTC Therapeutics showcased a remarkable growth trajectory, with revenue surging by over 3,900%, from $22.9 million in 2014 to $937.8 million in 2023.
These contrasting revenue trends highlight the dynamic nature of the pharmaceutical industry, where innovation and strategic positioning can lead to significant financial outcomes. As the industry continues to evolve, monitoring these trends will be essential for making informed investment decisions.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Examining Key Revenue Metrics
Revenue Showdown: Novartis AG vs Teva Pharmaceutical Industries Limited
Amgen Inc. vs Teva Pharmaceutical Industries Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Performance Compared
Revenue Insights: Teva Pharmaceutical Industries Limited and United Therapeutics Corporation Performance Compared
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs ADMA Biologics, Inc.
Comparing Revenue Performance: Teva Pharmaceutical Industries Limited or Celldex Therapeutics, Inc.?
Cytokinetics, Incorporated or PTC Therapeutics, Inc.: Who Leads in Yearly Revenue?
PTC Therapeutics, Inc. or ACADIA Pharmaceuticals Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: PTC Therapeutics, Inc. vs Mesoblast Limited
Revenue Showdown: PTC Therapeutics, Inc. vs Novavax, Inc.